Author:
Jiang Kan,Chen Ximing,Zhang Wei,Guo Yehong,Liu Guangxiu
Abstract
Abstract
Background
New antibiotics are urgently needed in clinical treatment of superdrug-resistant bacteria. Nonribosomal peptides (NRPs) are a major source of antibiotics because they exhibit structural diversity, and unique antibacterial mechanisms and resistance. Analysis of gene clusters of S. agglomeratus 5-1-3 showed that Clusters 3, 6, 12, 21, and 28 were used to synthesize NRPs. Here, we examined secondary metabolites of S. agglomeratus 5-1-3 isolated from soils in the Qinghai-Tibet Plateau, China, for NRPs with antibacterial activity.
Results
We isolated a total of 36 Streptomyces strains with distinct colony morphological characteristics from 7 soil samples. We screened 8 Streptomyces strains resistant to methicillin-resistant Staphylococcus aureus (MRSA). We then selected S. agglomeratus 5-1-3 for further study based on results of an antibacterial activity test. Here, we isolated three compounds from S. agglomeratus 5-1-3 and characterized their properties. The crude extract was extracted with ethyl acetate and purified with column chromatography and semipreparative high-performance liquid chromatography (HPLC). We characterized the three compounds using NMR analyses as echinomycin (1), 5,7,4ʹ-trihydroxy-3.3′,5′-trimethoxy flavone (2), and 2,6,2′, 6′-tetramethoxy-4,4-bis(2,3-epoxy-1-hydroxypropyl)-biphenyl (3). We tested the antibacterial activity of pure compounds from strain 5-1-3 with the Oxford cup method. NRP echinomycin (1) showed excellent anti-MRSA activity with a minimum inhibitory concentration (MIC) of 2.0 μg/mL. Meanwhile, MIC of compound 2 and 3 was 128.0 μg/mL for both. In addition, 203 mg of echinomycin was isolated from 10 L of the crude extract broth of strain 5-1-3.
Conclusion
In this study, S. agglomeratus 5-1-3 with strong resistance to MRSA was isolated from the soils in the Qinghai-Tibet Plateau. Strain 5-1-3 had a high yield of echinomycin (1) an NRP with a MIC of 2 μg/mL against MRSA. We propose that echinomycin derived from S. agglomeratus 5-1-3 may be a potent antibacterial agent for pharmaceutical use.
Funder
Natural Science Foundation of Gansu Province, China
Doctoral Research Foundation Project of Gansu Agricultural University
Research Program Sponsored by the Key Laboratory of Extreme Environmental Microbial Resources and Engineering
West Light Foundation of The Chinese Academy of Sciences
Scientific Project of Gansu Province
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference44 articles.
1. Cusumano ZT, Klein RD, Hultgren SJ. Innovative solutions to sticky situations: antiadhesive strategies for treating bacterial infections. Microbiol Spect. 2016. https://doi.org/10.1128/microbiolspec.VMBF-0023-2015.
2. Khan A, Wilson B, Gould IM. Current and future treatment options for community-associated MRSA infection. Expert Opin Pharmacother. 2018;19(5):457–70.
3. Aguayoreyes A, Quezadaaguiluz M, Mella S. Molecular basis of methicillin-resistancein Staphylococcus aureus. Rev Chilena Infectol. 2018;35(1):7–14.
4. Wang D, Xie KP, Zou D, Meng M, Xie MJ. Inhibitory effects of silybin on the efflux pump of methicillin-resistant Staphylococcus aureus. Mol Med Rep. 2018;18(1):827–33.
5. Zou D, Xie KP, Wang HT, Chen YX, Xie MJ. Inhibitory effects of biochanin A on the efflux pump of methicillin-resistant Staphylococcus aureus (MRSA). Acta Microbiol Sin. 2014;54(10):1204–11.